-
Yuan, J., Jiang, X., Lan, H., Zhang, X., Ding, T., Yang, F., Zeng, D., Yong, J., Niu, B., & Xiao, S.
Multi-Omics Analysis of the Therapeutic Value of MAL2 Based on Data Mining in Human Cancers
-
Zhao Xiaobao,et al
Structure-Activity Relationship Studies of Substituted 2-Phenyl-1,2,4-triazine-3,5(2 H,4 H)-dione Analogues: Development of Potent eEF2K Degraders against Triple-Negative Breast Cancer
-
Li, X., Jiang, S., Jiang, T., Sun, X., Guan, Y., Fan, S., & Cheng, Y.
LEM Domain Containing 1 Acts as a Novel Oncogene and Therapeutic Target for Triple-Negative Breast Cancer
-
Feng, Z. H., Zheng, L., Yao, T., Tao, S. Y., Wei, X. A., Zheng, Z. Y., Zheng, B. J., Zhang, X. Y., Huang, B., Liu, J. H., Chen, Y. L., Shan, Z., Yuan, P. T., Wang, C. G., Chen, J., Shen, S. Y., & Zhao, F. D.
EIF4A3-induced circular RNA PRKAR1B promotes osteosarcoma progression by miR-361-3p-mediated induction of FZD4 expression
-
Luo, S., Wang, W., Feng, J., & Li, R.
TEX10 Promotes the Tumorigenesis and Radiotherapy Resistance of Urinary Bladder Carcinoma by Stabilizing XRCC6
-
Gang Feng
Tex10 promotes stemness and EMT phenotypes in esophageal squamous cell carcinoma via the Wnt/β-catenin pathway